← Back
Data updated: Mar 10, 2026
INVENTIA HLTHCARE
Pharmaceuticals
INVENTIA HLTHCARE is a generic drug manufacturer with 4 FDA-approved products.
2017
Since
4
Drugs
-
Trials
52
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
VENLAFAXINE HYDROCHLORIDE 2026-01-30
Labeling
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
BUSPIRONE HYDROCHLORIDE 2025-10-06
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2025-09-26
Labeling
FLUOXETINE HYDROCHLORIDE 2025-09-26
Labeling
VENLAFAXINE HYDROCHLORIDE 2025-09-17
Labeling
VENLAFAXINE HYDROCHLORIDE 2025-09-02
Labeling
VENLAFAXINE HYDROCHLORIDE 2025-09-02
Labeling
TOLTERODINE TARTRATE 2025-08-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (2)
Company Info
- First Approval
- 2017-11-20
- Latest
- 2025-09-26
- Applications
- 5